Samalin Investment Counsel, LLC Abb Vie Inc. Transaction History

Samalin Investment Counsel, LLC

$207 Million
Q2 2024

A detailed history of Samalin Investment Counsel, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 5,351 shares of ABBV stock, worth $1.05 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

5,351

Previous 5,368 0.32%

Holding current value

$1.05 Million

Previous $977,000 6.14%

% of portfolio

0.44%

Previous 0.48%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $2,631 - $3,072	-17 Reduced 0.32%	5,351 $917,000
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $9,749 - $11,108	-61 Reduced 1.12%	5,368 $977,000
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $2,339 - $2,634	-17 Reduced 0.31%	5,429 $841,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $7,080 - $8,196	-53 Reduced 0.96%	5,446 $811,000
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $40,680 - $50,624	-307 Reduced 5.29%	5,499 $740,000
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $2,169 - $2,498	-15 Reduced 0.26%	5,806 $925,000
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $2,627 - $3,151	19 Added 0.33%	5,821 $941,000
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $14,897 - $17,086	-111 Reduced 1.88%	5,802 $779,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $442,035 - $561,971	-3,212 Reduced 35.2%	5,913 $906,000
Q1 2022 Oct 13, 2022	SELL	$131.98 - $163.75 $3,695 - $4,585	-28 Reduced 0.31%	9,125 $1.48 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $3,695 - $4,585	-28 Reduced 0.31%	9,125 $1.48 Billion
Q4 2021 Oct 13, 2022	SELL	$107.43 - $135.93 $144,493 - $182,825	-1,345 Reduced 12.81%	9,153 $1.24 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $144,493 - $182,825	-1,345 Reduced 12.81%	9,153 $1.24 Billion
Q3 2021 Oct 13, 2022	BUY	$106.4 - $120.78 $18,620 - $21,136	175 Added 1.7%	10,498 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $18,620 - $21,136	175 Added 1.7%	10,498 $1.13 Billion
Q2 2021 Oct 13, 2022	BUY	$105.21 - $117.21 $45,135 - $50,283	429 Added 4.34%	10,323 $1.16 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $9,258 - $10,314	88 Added 0.86%	10,323 $1.16 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $34,884 - $38,403	341 Added 3.45%	10,235 $1.11 Million
Q4 2020 Oct 13, 2022	SELL	$80.49 - $108.67 $26,320 - $35,535	-327 Reduced 3.2%	9,894 $1.06 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $26,320 - $35,535	-327 Reduced 3.2%	9,894 $1.06 Billion
Q3 2020 Oct 13, 2022	BUY	$85.91 - $100.83 $370,100 - $434,375	4,308 Added 72.86%	10,221 $895,000
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $641,318 - $752,695	7,465 Added 270.86%	10,221 $895,000
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $12,546 - $16,788	-171 Reduced 5.84%	2,756 $270,000
Q1 2020 May 04, 2020	SELL	$64.5 - $97.79 $9,352 - $14,179	-145 Reduced 4.72%	2,927 $223,000
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $221,583 - $277,248	3,072 New	3,072 $272,000

Others Institutions Holding ABBV

# of Institutions

3,697

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Abb Vie Inc. Transaction History